As of Q1'26 (2025-12-31), CRNC reported R&D Expenses of USD 24.7M and SG&A Expenses of USD 37.5M. This marks a notable increase in SG&A Expenses compared to previous quarters, while R&D Expenses continued their recent downward trend. Over the period from Q2'23 to Q1'26, R&D Expenses initially rose, peaking at USD 35.1M in Q4'23, before steadily declining to USD 24.7M by Q1'26. In contrast, SG&A Expenses remained relatively stable with minor fluctuations until a sharp spike in Q1'26, jumping from USD 18.7M in Q4'25 to USD 37.5M. This suggests a significant shift in expense allocation, with a recent emphasis on SG&A activities as R&D spending contracts.